TECregen
PrivateLast Round
Seed
Jan 8, 2026
Total Funding Raised
$12.6M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
TECregen is a biotechnology company developing a new class of biologics, called thymopoietics, designed to regenerate the thymus and restore immune function.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
TECregen Comparables
Compare TECregen with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Tolerance Bio, Inc. | 80% | |
| ThymoFox | 79% | |
| Thymmune Therapeutics | 76% |
TECregen Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jan 8, 2026 |
Key People
Founding team and executive leadership
TECregen Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| JFG Life Sciences Foundation of the University of Basel | Seed |
| Boehringer Ingelheim Venture Fund | Seed |
| LifeSpan Vision Ventures | Seed |
| CARMA FUND | Seed |
| High-Tech Gründerfonds | Seed |
| Eos | Seed |
| Zurcher Kantonalbank | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 20, 2026
Grew 30% QoQ, from 10 to 13 employees.
- Jan 30, 2026
Dr. Klaas Zuideveld appointed as new Chief Executive Officer.
TECregen Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about TECregen's valuation, stock price, and market status.
Is TECregen a public or private company?
TECregen is a private company.
What is the current stock price of TECregen?
TECregen is a private company with no public stock price. No recent secondary market data is available.
How much is TECregen worth (valuation)?
Valuation information for TECregen is not publicly available.
Can I buy TECregen stock?
TECregen shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was TECregen's last funding round?
TECregen's most recent funding round was Seed on January 8, 2026.
Who are the main investors in TECregen?
Key investors in TECregen include Boehringer Ingelheim Venture Fund.
Will TECregen IPO soon?
No public IPO plans have been announced for TECregen.
How can I track TECregen secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor TECregen's secondary market activity and sign up for updates.